Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (36471) 36471
Book Review (6118) 6118
Publication (2088) 2088
Newsletter (1057) 1057
Newspaper Article (833) 833
Book Chapter (178) 178
Transcript (115) 115
Magazine Article (98) 98
Conference Proceeding (92) 92
Book / eBook (56) 56
Trade Publication Article (35) 35
Web Resource (30) 30
Dissertation (17) 17
Reference (14) 14
Data Set (8) 8
Paper (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (30586) 30586
humans (24710) 24710
male (17345) 17345
female (14606) 14606
cholesterol (13690) 13690
middle aged (11834) 11834
animals (9354) 9354
adult (9107) 9107
atherosclerosis (8692) 8692
lipoproteins (8606) 8606
lipids (8225) 8225
low density lipoproteins (7832) 7832
risk factors (7422) 7422
aged (6968) 6968
triglycerides - blood (5756) 5756
cholesterol - blood (5457) 5457
cardiovascular disease (5142) 5142
lipids - blood (4800) 4800
cholesterol, hdl - blood (4624) 4624
triglycerides (4517) 4517
cholesterol, ldl - blood (4464) 4464
low-density-lipoprotein (4272) 4272
research (4077) 4077
cardiac & cardiovascular systems (3946) 3946
biochemistry & molecular biology (3930) 3930
diabetes (3925) 3925
pharmacology & pharmacy (3877) 3877
metabolism (3831) 3831
endocrinology & metabolism (3799) 3799
coronary-heart-disease (3771) 3771
analysis (3734) 3734
lipoproteins - blood (3607) 3607
peripheral vascular disease (3535) 3535
cardiovascular-disease (3517) 3517
low density lipoprotein (3509) 3509
abridged index medicus (3487) 3487
mice (3456) 3456
physiological aspects (3354) 3354
statins (3321) 3321
risk (3310) 3310
rats (3255) 3255
hypercholesterolemia (3197) 3197
health aspects (3112) 3112
nutrition & dietetics (3060) 3060
cardiovascular diseases (3037) 3037
high-density-lipoprotein (3016) 3016
density-lipoprotein cholesterol (2891) 2891
inflammation (2796) 2796
lipoproteins, hdl - blood (2788) 2788
plasma (2725) 2725
oxidative stress (2685) 2685
diet (2641) 2641
lipoproteins, ldl - blood (2641) 2641
care and treatment (2568) 2568
metabolic syndrome (2567) 2567
apolipoproteins (2512) 2512
obesity (2489) 2489
disease (2482) 2482
coronary heart disease (2426) 2426
insulin resistance (2335) 2335
myocardial-infarction (2301) 2301
treatment outcome (2273) 2273
proteins (2210) 2210
medical research (2208) 2208
glucose (2169) 2169
mortality (2167) 2167
hypertension (2127) 2127
studies (2127) 2127
cardiovascular (2120) 2120
body mass index (2087) 2087
biomarkers - blood (2057) 2057
type 2 diabetes (2036) 2036
c-reactive protein (2026) 2026
insulin-resistance (2013) 2013
liver (1995) 1995
blood cholesterol (1968) 1968
cholesterol - metabolism (1961) 1961
lipid metabolism (1950) 1950
blood pressure (1944) 1944
medicine, general & internal (1940) 1940
lipoprotein (1925) 1925
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1904) 1904
medicine, research & experimental (1874) 1874
heart-disease (1861) 1861
double-blind method (1858) 1858
medicine (1849) 1849
blood lipids (1835) 1835
prevention (1810) 1810
risk-factors (1802) 1802
dyslipidemia (1792) 1792
time factors (1766) 1766
liver - metabolism (1764) 1764
rodents (1750) 1750
medicine & public health (1745) 1745
insulin (1736) 1736
adolescent (1727) 1727
drug therapy (1709) 1709
cardiology (1674) 1674
medicine, experimental (1665) 1665
hdl (1661) 1661
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (40) 40
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UofT at Mississauga - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Missing (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (38364) 38364
German (93) 93
Russian (86) 86
Chinese (80) 80
Spanish (55) 55
French (53) 53
Italian (26) 26
Japanese (25) 25
Polish (22) 22
Portuguese (10) 10
Hungarian (9) 9
Turkish (7) 7
Czech (4) 4
Korean (3) 3
Ukrainian (3) 3
Bulgarian (2) 2
Swedish (2) 2
Croatian (1) 1
Dutch (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol: A Randomized Controlled Trial
by Nicholls, Stephen J and Brewer, H. Bryan and Kastelein, John J. P and Krueger, Kathryn A and Wang, Ming-Dauh and Shao, Mingyuan and Hu, Bo and McErlean, Ellen and Nissen, Steven E
JAMA, ISSN 0098-7484, 11/2011, Volume 306, Issue 19, pp. 2099 - 2109
CONTEXT Interest remains high in cholesteryl ester transfer protein (CETP) inhibitors as cardioprotective agents. Few studies have documented the efficacy and... 
LIPID-LEVEL MANAGEMENT | MEDICINE, GENERAL & INTERNAL | EVENTS | ESTER TRANSFER PROTEIN | HIGH-RISK | ATHEROSCLEROSIS | PREVENTION | TORCETRAPIB | PRAVASTATIN | CORONARY-HEART-DISEASE | HIGH-DENSITY-LIPOPROTEIN | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Dyslipidemias - drug therapy | Benzodiazepines - pharmacology | Double-Blind Method | Cholesterol, HDL - drug effects | Pyrimidines - administration & dosage | Simvastatin - administration & dosage | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Rosuvastatin Calcium | Cholesterol, LDL - drug effects | Male | Treatment Outcome | Fluorobenzenes - administration & dosage | Atorvastatin Calcium | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Benzodiazepines - administration & dosage | Female | Aged | Drug Therapy, Combination | Sulfonamides - administration & dosage | Inhibitor drugs | Drug therapy | Statins | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function. A Randomized, Placebo-Controlled, Magnetic Resonance Imaging Study
by Lee, Justin M.S and Robson, Matthew D and Yu, Ly-Mee and Shirodaria, Cheerag C and Cunnington, Colin and Kylintireas, Ilias and Digby, Janet E and Bannister, Thomas and Handa, Ashok and Wiesmann, Frank and Durrington, Paul N and Channon, Keith M and Neubauer, Stefan and Choudhury, Robin P
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2009, Volume 54, Issue 19, pp. 1787 - 1794
Objectives: Our aim was to determine the effects of high-dose (2 g) nicotinic acid (NA) on progression of atherosclerosis and measures of vascular function.... 
atherosclerosis | magnetic resonance imaging | carotid | HDL cholesterol | INTIMA-MEDIA THICKNESS | CARDIAC & CARDIOVASCULAR SYSTEMS | CHOLESTEROL | SAFETY | ENDOTHELIAL FUNCTION | HIGH-DENSITY-LIPOPROTEIN | CLINICAL-TRIALS | HIGH-RESOLUTION | DOUBLE-BLIND | NIACIN NIASPAN | CORONARY-HEART-DISEASE | Tunica Media - pathology | Tunica Media - drug effects | Humans | Middle Aged | Tunica Intima - physiopathology | Carotid Artery Diseases - physiopathology | Male | Niacin - pharmacology | Niacin - administration & dosage | Niacin - therapeutic use | Time Factors | Carotid Artery Diseases - pathology | Cholesterol, LDL - blood | Female | Carotid Artery Diseases - drug therapy | Double-Blind Method | Drug Administration Schedule | Cholesterol, HDL - drug effects | Cholesterol, LDL - drug effects | Treatment Outcome | Hypolipidemic Agents - pharmacology | Tunica Intima - drug effects | Magnetic Resonance Imaging | Confounding Factors (Epidemiology) | Tunica Intima - pathology | Hypolipidemic Agents - administration & dosage | Triglycerides - blood | Cholesterol, HDL - blood | Aged | Hypolipidemic Agents - therapeutic use | Tunica Media - physiopathology | Delayed-Action Preparations | Lipoproteins | Nuclear magnetic resonance--NMR | Pulmonary arteries | Coronary vessels | Mortality | Atherosclerosis | Cardiovascular disease | Diabetes | Acute coronary syndromes | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Long‐term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetes
by Bode, B and Stenlöf, K and Harris, S and Sullivan, D and Fung, A and Usiskin, K and Meininger, G
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 03/2015, Volume 17, Issue 3, pp. 294 - 303
Aims: The long-term efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, was evaluated over 104 weeks in patients aged 55-80... 
phase | study | type 2 diabetes | inhibitor | SGLT2 | canagliflozin | III | Phase III study | Type 2 diabetes | Canagliflozin | SGLT2 inhibitor | GLYCEMIC CONTROL | PLACEBO | BACKGROUND METFORMIN | ADD-ON | SITAGLIPTIN | MELLITUS | phase III study | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | POOLED ANALYSIS | GLIMEPIRIDE | INHIBITOR | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Glycated Hemoglobin A - drug effects | Body Weight - drug effects | Male | Osmolar Concentration | Urinary Tract Infections - chemically induced | Aged, 80 and over | Cholesterol, LDL - blood | Female | Glucosides - therapeutic use | Blood Pressure - drug effects | Metformin - administration & dosage | Glucosides - adverse effects | Hypoglycemic Agents - therapeutic use | Fasting | Double-Blind Method | Cholesterol, HDL - drug effects | Cholesterol, LDL - drug effects | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Diuresis - drug effects | Cholesterol, HDL - blood | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Mycoses - chemically induced | Glucose metabolism | Low density lipoproteins | Mycoses | Hemoglobin | Urinary tract infections | Blood lipids | Glucose | Dextrose | Medical research | Blood pressure | Diabetes | Cholesterol | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text RVX-208. A Small Molecule That Increases Apolipoprotein A-I and High-Density Lipoprotein Cholesterol In Vitro and In Vivo
by Bailey, Dana and Jahagirdar, Ravi and Gordon, Allan and Hafiane, Anouar and Campbell, Steven and Chatur, Safia and Wagner, Gregory S and Hansen, Henrik C and Chiacchia, Fabrizio S and Johansson, Jan and Krimbou, Larbi and Wong, Norman C.W and Genest, Jacques
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2010, Volume 55, Issue 23, pp. 2580 - 2589
Objectives: The aim of this study was to determine whether a novel small molecule RVX-208 affects apolipoprotein (apo)A-I and high-density lipoprotein... 
atherosclerosis | reverse cholesterol transport | HDL-based therapy | apoA-I | ABCA1 | CORONARY-ARTERY DISEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | HUMAN PLASMA | PARTICLES | HEART-DISEASE | METABOLISM | HDL CHOLESTEROL | ABCG1 | Molecular Weight | Follow-Up Studies | Humans | Cercopithecus aethiops | Macaca fascicularis | Male | Hep G2 Cells - drug effects | Dose-Response Relationship, Drug | Female | Quinazolines - chemistry | Apolipoprotein A-I - drug effects | Disease Models, Animal | Cricetinae | Apolipoprotein A-I - biosynthesis | Drug Administration Schedule | Risk Assessment | Cholesterol, HDL - drug effects | Cholesterol, HDL - metabolism | Cells, Cultured | Probability | Apolipoprotein A-I - metabolism | Random Allocation | Animals | Hep G2 Cells - metabolism | Cholesterol, HDL - blood | In Vitro Techniques | Quinazolines - pharmacology | Apolipoprotein A-I - blood | Studies | Lipoproteins | Atherosclerosis | Cardiovascular disease | Laboratory animals | Apolipoproteins | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Ambient Particulate Pollutants in the Ultrafine Range Promote Early Atherosclerosis and Systemic Oxidative Stress
by Araujo, Jesus A and Barajas, Berenice and Kleinman, Michael and Wang, Xuping and Bennett, Brian J and Gong, Ke Wei and Navab, Mohamad and Harkema, Jack and Sioutas, Constantinos and Lusis, Aldons J and Nel, Andre E
Circulation Research, ISSN 0009-7330, 03/2008, Volume 102, Issue 5, pp. 589 - 596
Air pollution is associated with significant adverse health effects, including increased cardiovascular morbidity and mortality. Exposure to particulate matter... 
HDL | Oxidative stress | Air pollution | Ultrafine particles | Atherosclerosis | atherosclerosis | SIMULTANEOUS IN-VIVO | DIESEL EXHAUST PARTICLES | CARDIAC & CARDIOVASCULAR SYSTEMS | LIPID-PEROXIDATION | LONG-TERM EXPOSURE | US CITIES | PROTEIN RESPONSE | VITRO EVALUATION | AIR-POLLUTION | ultrafine particles | ENDOTHELIAL-CELLS | LOS-ANGELES | PERIPHERAL VASCULAR DISEASE | air pollution | HEMATOLOGY | oxidative stress | Particulate Matter - toxicity | Antioxidants - metabolism | Atherosclerosis - genetics | Coculture Techniques | Humans | Male | Lipoproteins, HDL - pharmacology | Malondialdehyde - analysis | Particulate Matter - chemistry | Liver - drug effects | Lipoproteins, HDL - drug effects | Inhalation Exposure | Lipid Peroxidation - drug effects | Malondialdehyde - metabolism | Atherosclerosis - pathology | Atherosclerosis - chemically induced | Liver - metabolism | Mice, Inbred C57BL | Biomarkers - analysis | Cells, Cultured | Lipoproteins, LDL - pharmacology | Disease Progression | Liver - chemistry | Mice, Knockout | Aorta - pathology | Monocytes - drug effects | Particle Size | Cell Movement - drug effects | Animals | Apolipoproteins E - genetics | Polycyclic Aromatic Hydrocarbons - analysis | Atmosphere Exposure Chambers | Mice | Oxidative Stress - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: Insights from illustrate (investigation of lipid level management using coronary ultrasound to assess reduction of atherosclerosis by CETP inhibition and HDL elevation)
by Nicholls, Stephen J and Tuzcu, E. Murat and Brennan, Danielle M and Tardif, Jean-Claude and Nissen, Steven E
Circulation, ISSN 0009-7322, 12/2008, Volume 118, Issue 24, pp. 2506 - 2514
Background-Despite favorable effects on high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol, the cholesteryl ester transfer... 
Torcetrapib | High-density lipoprotein cholesterol | Atherosclerosis | Ultrasonics | atherosclerosis | ultrasonics | NADPH OXIDASE | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | ANGIOTENSIN-II | RANDOMIZED CONTROLLED-TRIAL | FED RABBITS | HEART-DISEASE | PRIMARY-PREVENTION | HIGH-RISK | high-density lipoprotein cholesterol | PERIPHERAL VASCULAR DISEASE | SMOOTH-MUSCLE-CELLS | torcetrapib | APOLIPOPROTEIN-A-I | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Lipoproteins, HDL - blood | Humans | Middle Aged | Male | Coronary Artery Disease - drug therapy | Quinolines - administration & dosage | Disease Progression | Sodium - blood | Atorvastatin Calcium | Coronary Artery Disease - diagnostic imaging | Heptanoic Acids - toxicity | Lipoproteins, HDL - drug effects | Pyrroles - administration & dosage | Pyrroles - toxicity | Ultrasonography | Heptanoic Acids - administration & dosage | Female | Potassium - blood | Aged | Quinolines - toxicity | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Troglitazone Inhibits Atherosclerosis in Apolipoprotein E–Knockout Mice: Pleiotropic Effects on CD36 Expression and HDL
by Chen, Zhong and Ishibashi, Shun and Perrey, Stéphane and Osuga, Jun-ichi and Gotoda, Takanari and Kitamine, Tetsuya and Tamura, Yoshiaki and Okazaki, Hiroaki and Yahagi, Naoya and Iizuka, Yoko and Shionoiri, Futoshi and Ohashi, Ken and Harada, Kenji and Shimano, Hitoshi and Nagai, Ryozo and Yamada, Nobuhiro
Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, ISSN 1079-5642, 03/2001, Volume 21, Issue 3, pp. 372 - 377
Abstract —Atherosclerotic coronary heart disease is a common complication of the insulin resistance syndrome that can occur with or without diabetes mellitus.... 
Lipoproteins | CD36 | Peroxisome proliferator-activated receptor | Thiazolidinediones | Atherosclerosis | atherosclerosis | thiazolidinediones | ACTIVATED RECEPTOR-GAMMA | ZUCKER FATTY RATS | OXIDIZED LDL | LOW-DENSITY LIPOPROTEINS | INSULIN-RESISTANCE | CARDIOVASCULAR-DISEASE | VASCULAR INFLAMMATION | GENE-EXPRESSION | PPAR-GAMMA | PERIPHERAL VASCULAR DISEASE | peroxisome proliferator-activated receptor | HEMATOLOGY | lipoproteins | CD36 Antigens - genetics | Lipoproteins, HDL - blood | Body Weight - drug effects | Male | Aorta - metabolism | Insulin - blood | RNA, Messenger - metabolism | Macrophages, Peritoneal - cytology | Chromans - pharmacology | Time Factors | Lipoproteins, HDL - drug effects | Lipids - blood | Fatty Acids, Nonesterified - blood | Female | Macrophages, Peritoneal - drug effects | RNA, Messenger - drug effects | Lipoprotein Lipase - genetics | Aorta - drug effects | Mice, Inbred C57BL | RNA, Messenger - genetics | Cells, Cultured | Receptors, Cytoplasmic and Nuclear - genetics | Lipoproteins - blood | Transcription Factors - genetics | Hypoglycemic Agents - pharmacology | Mice, Knockout | Aorta - pathology | Blood Glucose - drug effects | Gene Expression Regulation - drug effects | Arteriosclerosis - prevention & control | Blotting, Northern | Animals | Apolipoproteins E - genetics | Mice | Thiazoles - pharmacology | Lipoproteins - drug effects | Blood Glucose - metabolism | Macrophages, Peritoneal - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: A randomized, double-blind, controlled study
by Rosenson, Robert S and Otvos, James D and Hsia, Judith
Diabetes Care, ISSN 0149-5992, 06/2009, Volume 32, Issue 6, pp. 1087 - 1091
OBJECTIVE - The purpose of this study was to examine the effects of statin therapy on lipoprotein particle concentrations inpatients with the metabolic... 
TRIAL | PANEL | MAGNETIC-RESONANCE-SPECTROSCOPY | THERAPY | CHOLESTEROL | SUBCLASSES | SIZE | ENDOCRINOLOGY & METABOLISM | LOW-DENSITY-LIPOPROTEIN | RISK | Dyslipidemias - complications | Cholesterol - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Lipoproteins, LDL - drug effects | Placebos | Cholesterol, LDL - blood | Female | Pyrroles - therapeutic use | Apolipoprotein A-I - drug effects | Body Mass Index | Dyslipidemias - drug therapy | Double-Blind Method | Cholesterol, HDL - drug effects | Rosuvastatin Calcium | Cholesterol, LDL - drug effects | European Continental Ancestry Group | Metabolic Syndrome - complications | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cholesterol, HDL - blood | Aged | Fluorobenzenes - therapeutic use | Lipoproteins, LDL - blood | Apolipoprotein A-I - blood | Medical research | Care and treatment | Cardiac patients | Low density lipoproteins | Medicine, Experimental | Rosuvastatin | Research | All terrain vehicles | Coronary heart disease | Cholesterol | Cardiovascular agents | Diseases | Plasma | Nuclear magnetic resonance--NMR | Nutrition | Atoms & subatomic particles | Cardiovascular disease | Metabolic syndrome | Patients | Diet | Risk assessment | Comparative studies | Clinical medicine | Drug therapy | Index Medicus | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis). Final Results and the Impact of Medication Adherence, Dose, and Treatment Duration
by Villines, Todd C and Stanek, Eric J and Devine, Patrick J and Turco, Mark and Miller, Michael and Weissman, Neil J and Griffen, Len and Taylor, Allen J
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2010, Volume 55, Issue 24, pp. 2721 - 2726
Objectives: This report describes the final results of the ARBITER 6-HALTS (Arterial Biology for the Investigation of the Treatment Effects of Reducing... 
atherosclerosis | lipids | risk factors | INTIMA-MEDIA THICKNESS | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | PREVENTION | COMBINATION | STATINS | THERAPY | DISEASE | EXTENDED-RELEASE NIACIN | PROGRESSION | Carotid Artery, Common - diagnostic imaging | Single-Blind Method | Follow-Up Studies | Humans | Ezetimibe | Male | Dose-Response Relationship, Drug | Niacin - administration & dosage | Time Factors | Ultrasonography | Atherosclerosis - diagnosis | Cholesterol, LDL - blood | Female | Tunica Intima - diagnostic imaging | Coronary Disease - blood | Atherosclerosis - drug therapy | Cholesterol, HDL - drug effects | Cholesterol, LDL - drug effects | Treatment Outcome | Coronary Disease - diagnosis | Atherosclerosis - blood | Medication Adherence | Azetidines - administration & dosage | Anticholesteremic Agents - administration & dosage | Cholesterol, HDL - blood | Coronary Disease - drug therapy | Aged | Lipoproteins | Ultrasonic imaging | Vitamin B | Cardiovascular disease | Lipids | Blood pressure | Triglycerides | Drug therapy | Variance analysis | Drug dosages | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials
by Mensink, R.P and Zock, P.L and Kester, A.D.M and Katan, M.B
American Journal of Clinical Nutrition, ISSN 0002-9165, 01/2003, Volume 77, Issue 5, pp. 1146 - 1155
Background: The effects of dietary fats on the risk of coronary artery disease (CAD) have traditionally been estimated from their effects on LDL cholesterol.... 
Carbohydrates | Serum lipoproteins | Diet | Fatty acids | Coronary artery disease risk | carbohydrates | SUNFLOWER OIL | fatty acids | PALMITIC ACID | DENSITY-LIPOPROTEIN-CHOLESTEROL | CORONARY HEART-DISEASE | TRANS-FATTY | HEALTHY-YOUNG MEN | NUTRITION & DIETETICS | PLASMA-LIPIDS | HYDROGENATED SOYBEAN OIL | STEARIC-ACID | coronary artery disease risk | diet | NORMOLIPIDEMIC MEN | serum lipoproteins | Dietary Carbohydrates - administration & dosage | Cardiovascular Diseases - etiology | Fatty Acids - chemistry | Cholesterol, HDL - drug effects | Dietary Carbohydrates - pharmacology | Cholesterol - blood | Humans | Risk Factors | Fatty Acids, Unsaturated - pharmacology | Male | Biomarkers - blood | Lipoproteins - blood | Isomerism | Cardiovascular Diseases - blood | Cholesterol, HDL - blood | Fatty Acids - administration & dosage | Adult | Female | Fatty Acids - pharmacology | Fatty Acids, Unsaturated - administration & dosage | Nutrition | Dietary supplements | Dietary fat | Research | Coronary heart disease | Absorption (Physiology) | Cholesterol | Prevention | Proteolipids | Lipoproteins | Risk factors (Health) | Analysis | Physiological aspects | Causes of | Serum | Health aspects | Index Medicus | Abridged Index Medicus | hydrogenated soybean oil | density-lipoprotein-cholesterol | sunflower oil | coronary heart-disease | stearic-acid | healthy-young men | palmitic acid | plasma-lipids | trans-fatty | normolipidemic men
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial
by Hovingh, G Kees, Dr and Kastelein, John J P, Prof and van Deventer, Sander J H, Prof and Round, Patrick and Ford, John and Saleheen, Danish and Rader, Daniel J, Prof and Brewer, H Bryan, Prof and Barter, Philip J, Prof
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9992, pp. 452 - 460
Summary Background Dyslipidaemia remains a significant risk factor for cardiovascular disease and additional lipid-modifying treatments are warranted to... 
Internal Medicine | EFFLUX CAPACITY | CETP | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR EVENTS | DISEASE | TORCETRAPIB | RISK | HDL CHOLESTEROL | ACUTE CORONARY SYNDROME | LIPIDS | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Humans | Middle Aged | Male | Fluorobenzenes - administration & dosage | Quinolines - administration & dosage | Quinolines - pharmacology | Young Adult | Netherlands | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Adult | Cholesterol, LDL - blood | Female | Dyslipidemias - drug therapy | Double-Blind Method | Cholesterol, HDL - drug effects | Pyrimidines - administration & dosage | Rosuvastatin Calcium | Cholesterol, LDL - drug effects | Treatment Outcome | Atorvastatin Calcium | Adolescent | Cholesterol, HDL - blood | Denmark | Aged | Sulfonamides - administration & dosage | Clinical trials | Cholesterol | Proteins | Studies | Lipids | Low density lipoprotein | Drug dosages | Statins | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
by Kühnast, Susan and Van Der Tuin, Sam J.L and Van Der Hoorn, Jose W.A and Van Klinken, Jan B and Simic, Branko and Pieterman, Elsbet and Havekes, Louis M and Landmesser, Ulf and Lüscher, Thomas F and Van Dijk, Ko Willems and Rensen, Patrick C.N and Jukema, J. Wouter and Princen, Hans M.G
European Heart Journal, ISSN 0195-668X, 01/2015, Volume 36, Issue 1, pp. 39 - 48
The present study is the first intervention study in a well-established, translational mouse model for hyperlipidaemia and atherosclerosis showing that... 
Anacetrapib | Non-HDL-cholesterol | Atherosclerosis | HDL-cholesterol | Atorvastatin | HDL function | Cholesteryl ester transfer protein | INCREASES HDL | CARDIAC & CARDIOVASCULAR SYSTEMS | RANDOMIZED-TRIALS | TORCETRAPIB | CETP INHIBITOR | VASCULAR-DISEASE | HIGH-DENSITY-LIPOPROTEIN | LDL CHOLESTEROL | HIGH-RISK | ESTER-TRANSFER PROTEIN | MICE | Index Medicus | Basic Science
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights